Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
475
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Samsung Biologics
•
27 Oct 2016 04:46
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
Kemp Dolliver, CFA
229 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Oct 2016 12:40
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...
Singapore Exchange Ltd (SGX)
Follow
3.4k Views
Share
bearish
•
Samsung Biologics
•
21 Oct 2016 06:54
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
Sanghyun Park
Follow
254 Views
Share
bearish
•
Celltrion Inc
•
19 Oct 2016 11:06
The Chickens Are Ready to Roost
Several recent developments confirm our thesis that Inflectra's US sales in 2017 will fall far short of management's 2017 forecast. First, Pfizer's...
Kemp Dolliver, CFA
195 Views
Share
bullish
•
Celltrion Inc
•
19 Oct 2016 03:26
Teva May Buy Celltrion - Implications for Celltrion & Celltrion Healthcare
How should we interpret Teva's potential acquisition of Celltrion? Is this for real? Well, Teva may still be very interested in acquiring Celltrion...
Sanghyun Park
Follow
200 Views
Share
First
Previous
86
87
88
89
90
91
92
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x